Callan Family Office LLC Takes Position in Cardinal Health, Inc. $CAH

by · The Cerbat Gem

Callan Family Office LLC purchased a new stake in Cardinal Health, Inc. (NYSE:CAHFree Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 4,499 shares of the company’s stock, valued at approximately $756,000.

A number of other institutional investors and hedge funds also recently modified their holdings of CAH. Wellington Management Group LLP increased its stake in shares of Cardinal Health by 1,666.7% in the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock valued at $328,470,000 after acquiring an additional 2,249,241 shares during the last quarter. JPMorgan Chase & Co. increased its stake in Cardinal Health by 40.0% during the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock worth $575,327,000 after purchasing an additional 1,193,983 shares in the last quarter. Zurich Insurance Group Ltd FI increased its stake in Cardinal Health by 4,935.9% during the 1st quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock worth $130,434,000 after purchasing an additional 927,950 shares in the last quarter. Nuveen LLC bought a new stake in Cardinal Health during the 1st quarter worth approximately $106,065,000. Finally, T. Rowe Price Investment Management Inc. bought a new stake in Cardinal Health during the 1st quarter worth approximately $104,951,000. 87.17% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Evercore ISI lowered their target price on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research note on Wednesday, August 13th. Wells Fargo & Company reissued an “overweight” rating and set a $185.00 target price (up from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Robert W. Baird increased their target price on Cardinal Health from $197.00 to $203.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 13th. Argus set a $189.00 target price on Cardinal Health in a research note on Friday, August 22nd. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, October 8th. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $166.00.

Check Out Our Latest Analysis on Cardinal Health

Cardinal Health Stock Down 1.7%

NYSE:CAH opened at $154.26 on Tuesday. Cardinal Health, Inc. has a twelve month low of $106.98 and a twelve month high of $168.44. The business has a 50 day moving average price of $152.00 and a two-hundred day moving average price of $151.43. The company has a market cap of $36.65 billion, a P/E ratio of 23.92, a price-to-earnings-growth ratio of 1.33 and a beta of 0.71.

Cardinal Health (NYSE:CAHGet Free Report) last released its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. During the same quarter in the prior year, the firm posted $1.84 EPS. The business’s revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be issued a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health’s dividend payout ratio is presently 31.63%.

Insider Buying and Selling

In other news, insider Ola M. Snow sold 28,151 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the sale, the insider owned 15,431 shares of the company’s stock, valued at approximately $2,298,293.14. This represents a 64.59% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Michelle D. Greene sold 13,500 shares of the stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $2,009,070.00. Following the completion of the sale, the insider directly owned 14,976 shares of the company’s stock, valued at approximately $2,228,728.32. The trade was a 47.41% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 271,676 shares of company stock worth $40,489,525 in the last quarter. 0.12% of the stock is owned by company insiders.

Cardinal Health Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Read More

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).